OpenURL Connection Search

Select item for more details and to access through your institution.

Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01045-3
By:
- Derman, Benjamin A.;
- Cooperrider, Jennifer;
- Rosenblatt, Jacalyn;
- Avigan, David E.;
- Rampurwala, Murtuza;
- Barnidge, David;
- Major, Ajay;
- Karrison, Theodore;
- Jiang, Ken;
- Ramsland, Aubrianna;
- Kubicki, Tadeusz;
- Jakubowiak, Andrzej J.
Publication type:
Article
A PML-PPAR-? pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance.
Published in:
Nature Medicine, 2012, v. 18, n. 9, p. 1350, doi. 10.1038/nm.2882
By:
- Ito, Keisuke;
- Carracedo, Arkaitz;
- Weiss, Dror;
- Arai, Fumio;
- Ala, Ugo;
- Avigan, David E;
- Schafer, Zachary T;
- Evans, Ronald M;
- Suda, Toshio;
- Lee, Chih-Hao;
- Pandolfi, Pier Paolo
Publication type:
Article
Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study.
Published in:
British Journal of Haematology, 2019, v. 186, n. 5, p. e117, doi. 10.1111/bjh.15946
By:
- Mateos, Maria‐Victoria;
- Orlowski, Robert Z.;
- Ocio, Enrique M.;
- Rodríguez‐Otero, Paula;
- Reece, Donna;
- Moreau, Philippe;
- Munshi, Nikhil;
- Avigan, David E.;
- Siegel, David S.;
- Ghori, Razi;
- Farooqui, Mohammed Z. H.;
- Marinello, Patricia;
- San-Miguel, Jesus
Publication type:
Article
Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE‐013.
Published in:
British Journal of Haematology, 2019, v. 186, n. 3, p. e41, doi. 10.1111/bjh.15888
By:
- Ribrag, Vincent;
- Avigan, David E.;
- Green, Damian J.;
- Wise‐Draper, Trisha;
- Posada, Juan G.;
- Vij, Ravi;
- Zhu, Ying;
- Farooqui, Mohammed Z. H.;
- Marinello, Patricia;
- Siegel, David S.
Publication type:
Article
Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures.
Published in:
Journal of Clinical Apheresis, 2003, v. 18, n. 1, p. 37, doi. 10.1002/jca.10046
By:
- Schwaber, Mitchell J.;
- Krasner, Carolyn N.;
- Gold, Howard S.;
- Venkataraman, Lata;
- Avigan, David E.;
- Karchmer, Adolf W.;
- Uhl, Lynne
Publication type:
Article
Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma.
Published in:
NPJ Genomic Medicine, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41525-022-00340-x
By:
- Pilcher, William;
- Thomas, Beena E.;
- Bhasin, Swati S.;
- Jayasinghe, Reyka G.;
- Yao, Lijun;
- Gonzalez-Kozlova, Edgar;
- Dasari, Surendra;
- Kim-Schulze, Seunghee;
- Rahman, Adeeb;
- Patton, Jonathan;
- Fiala, Mark;
- Cheloni, Giulia;
- Kourelis, Taxiarchis;
- Dhodapkar, Madhav V.;
- Vij, Ravi;
- Mehr, Shaadi;
- Hamilton, Mark;
- Cho, Hearn Jay;
- Auclair, Daniel;
- Avigan, David E.
Publication type:
Article
Advances in the Development of Vaccines and Other Immunotherapies for Multiple Myeloma.
Published in:
Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 12, p. 670
By:
- Avigan, David E.
Publication type:
Article
PML targeting eradicates quiescent leukaemia-initiating cells.
Published in:
Nature, 2008, v. 453, n. 7198, p. 1072, doi. 10.1038/nature07016
By:
- Ito, Keisuke;
- Bernardi, Rosa;
- Morotti, Alessandro;
- Matsuoka, Sahoko;
- Saglio, Giuseppe;
- Ikeda, Yasuo;
- Rosenblatt, Jacalyn;
- Avigan, David E.;
- Teruya-Feldstein, Julie;
- Pandolfi, Pier Paolo
Publication type:
Article
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 413, doi. 10.1016/j.clml.2023.03.009
By:
- Terpos, Evangelos;
- Neri, Paola;
- van de Donk, Niels W.C.J.;
- D'Agostino, Mattia;
- Parekh, Samir;
- Jagannath, Sundar;
- Ludwig, Heinz;
- Avigan, David E.;
- Dhodapkar, Madhav V.;
- Raje, Noopur S.
Publication type:
Article
Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
Published in:
International Journal of Cancer, 2016, v. 139, n. 9, p. 1915, doi. 10.1002/ijc.30232
By:
- Pyzer, Athalia Rachel;
- Cole, Leandra;
- Rosenblatt, Jacalyn;
- Avigan, David E
Publication type:
Article
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy.
Published in:
International Journal of Hematology, 2023, v. 117, n. 5, p. 652, doi. 10.1007/s12185-023-03579-x
By:
- Russell, Brian M.;
- Avigan, David E.
Publication type:
Article
High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality.
Published in:
Transfusion, 2024, v. 64, n. 6, p. 1068, doi. 10.1111/trf.17864
By:
- Avigan, Zachary M.;
- Dias, Ajoy L.;
- Dodge, Laura E.;
- Arnason, Jon E.;
- Joyce, Robin M.;
- Liegel, Jessica;
- Rosenblatt, Jacalyn;
- Weinstock, Matthew J.;
- Avigan, David E.;
- Haspel, Richard L.
Publication type:
Article
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Published in:
2020
By:
- Foss, Francine M.;
- Wang, Xin Victoria;
- Luger, Selina M.;
- Jegede, Opeyemi;
- Miller, Kenneth B.;
- Stadtmauer, Edward A.;
- Whiteside, Theresa L.;
- Avigan, David E.;
- Gascoyne, Randall D.;
- Arber, Daniel;
- Wagner, Henry;
- Strair, Roger K.;
- Hogan, William J.;
- Sprague, Kellie A.;
- Lazarus, Hillard M.;
- Litzow, Mark R.;
- Tallman, Martin S.;
- Horning, Sandra J.
Publication type:
journal article
Case Report: Refractory Cryptosporidiosis after CAR T-Cell Therapy for Lymphoma.
Published in:
American Journal of Tropical Medicine & Hygiene, 2021, v. 105, n. 3, p. 651, doi. 10.4269/ajtmh.21-0246
By:
- Trottier, Caitlin A.;
- Yen, Christina F.;
- Malvar, Grace;
- Arnason, Jon;
- Avigan, David E.;
- Alonso, Carolyn D.
Publication type:
Article
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.
Published in:
2018
By:
- Fathi, Amir T.;
- Blonquist, Traci M.;
- Hernandez, Daniela;
- Amrein, Philip C.;
- Ballen, Karen K.;
- McMasters, Malgorzata;
- Avigan, David E.;
- Joyce, Robin;
- Logan, Emma K.;
- Hobbs, Gabriela;
- Brunner, Andrew M.;
- Joseph, Christelle;
- Perry, Ashley M.;
- Burke, Meghan;
- Behnan, Tanya;
- Foster, Julia;
- Bergeron, Meghan K.;
- Moran, Jenna A.;
- Ramos, Aura Y.;
- Som, Tina T.
Publication type:
journal article

Found: 15